Vimarsana
Biggest News Aggregation in the World

Page 38 - Genetic Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetic Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetic Technologies Today - Breaking & Trending Today

DNA test to predict odds of severe COVID-19 draws scrutiny - Vimarsana News

DNA test to predict odds of severe COVID-19 draws scrutiny

Science's COVID-19 reporting is supported by the Heising-Simons Foundation For people not yet vaccinated against COVID-19 or still nervous about venturing into crowds, the sales pitch may be alluring: Drool into a tube to provide your DNA and mail it off to see how likely you are to be among the 10% to 15% of people who will end up in the hospital or die from a SARS-CoV-2 infection. That's the promise of a $175 test an Australian company launched last week in the United States. It combines genetic data with someone's age, sex, and preexisting medical conditions to predict their risk of becomi...

12 Health Care Stocks Moving In Tuesday's After-Market Session - Vimarsana News

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) shares increased by 9.04% to $4.1 during Tuesday’s after-market session. Trading volume for this security closed at 10.1 million, accounting for 1726.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $239.0 million. Selecta Biosciences (NASDAQ:SELB) shares moved upwards by 8.12% to $3.86. Today’s trading volume for this security ended up closing at 130.4K shares, which is 11.74 percent of its average volume over the last 10...

Dengue fever drug company Island Pharmaceuticals surges 124 per cent on debut - Vimarsana News

Dengue fever drug company Island Pharmaceuticals surges 124 per cent on debut

Drug repurposing company Island Pharmaceuticals was started in 2017 after its founders decided there had to be a better way to treat mosquito-born viruses.

Source: afr.com
Business Scoop » March 17th: 'D-Day' For Deregulation Of Genetic Engineering - Vimarsana News

Business Scoop » March 17th: 'D-Day' For Deregulation Of Genetic Engineering

Business Scoop provides news and views on Business and Markets from New Zealand

March 17th: 'D-Day' For Deregulation Of Genetic Engineering - Vimarsana News

March 17th: 'D-Day' For Deregulation Of Genetic Engineering

Sunday, 14 March 2021, 5:39 pm Consultation on global proposals to deregulate Gene Editing will end on March 17th, with the public and food producers largely in the dark about the major implications. The coincidence in date for proposals in Australia and the UK is a 'D-Day' for food safety.[1] [2] "'D-Day' will mean Disaster Day, if products from Gene Editing are not regulated for safety for people and the environment and registered in a global database," said Jon Carapiet, spokesman for GE-Free NZ. Currently plants and animals produced with Gene Editing are regulated like other GMOs. Removi...